TCL Archive In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt August 22, 1986
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004